EcoDrugPlus

Ribosomal Protein L18

Ensembl ID : ENSBMUG00000016360
Gene Symbol: RPL18
3 Cross references
276 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSBMUG00000025608
Gene Symbol: RPL18A
3 Cross references
202 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSBMUG00000001730
Gene Symbol: RPL19
3 Cross references
256 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSBMUG00000000473
Gene Symbol: RPL22
3 Cross references
248 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSBMUG00000001476
Gene Symbol: RPL23
3 Cross references
217 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSBMUG00000010391
Gene Symbol: RPL24
3 Cross references
228 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSBMUG00000019389
Gene Symbol: RPL27
3 Cross references
198 Possible Orthologues:

Ribosomal Protein L27a

Ensembl ID : ENSBMUG00000001637
Gene Symbol: RPL27A
3 Cross references
198 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSBMUG00000006807
Gene Symbol: RPL28
3 Cross references
204 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSBMUG00000008110
Gene Symbol: RPL29
3 Cross references
340 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSBMUG00000000471
Gene Symbol: RPL3
3 Cross references
264 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSBMUG00000022606
Gene Symbol: RPL30
3 Cross references
202 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).